Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6,62 USD | +4,58% | -2,55% | -4,64% |
02/04 | KALA BIO, INC. : HC Wainwright herhaalt koopadvies | ZM |
29/03 | KALA BIO, Inc. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023 | CI |
Vakgebied
Aantal werknemers: 43
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mark Iwicki
CEO | Chief Executive Officer | 57 | 01-03-15 |
Mary Reumuth
DFI | Director of Finance/CFO | 48 | 01-02-14 |
Todd Bazemore
PSD | President | 53 | 20-11-17 |
Compliance Officer | 51 | 03-04-18 | |
Romulus Brazzell
CTO | Chief Tech/Sci/R&D Officer | 71 | 01-02-13 |
Investor Relations Contact | - | - | |
Darius Kharabi
PRN | Corporate Officer/Principal | 45 | 15-11-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Andrew Koven
BRD | Director/Board Member | 66 | 28-09-17 |
Gregory Perry
BRD | Director/Board Member | 63 | 05-03-18 |
Howard Rosen
BRD | Director/Board Member | 66 | 06-01-14 |
Charles Myers
BRD | Director/Board Member | 70 | 15-10-21 |
Mark Blumenkranz
BRD | Director/Board Member | 73 | 15-11-21 |
Mark Iwicki
CEO | Chief Executive Officer | 57 | 01-03-15 |
Marjan Farid
BRD | Director/Board Member | 50 | 31-10-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 2 816 454 | 2 311 005 ( 82,05 %) | 0 | 82,05 % |
Aandeel B | 0 | 51 246 | 0 | 0 |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,64% | 17,83 mln. | |
+27,49% | 659 mld. | |
+27,68% | 557 mld. | |
-4,31% | 359 mld. | |
+16,52% | 322 mld. | |
+9,72% | 297 mld. | |
+6,30% | 215 mld. | |
+4,80% | 210 mld. | |
-6,05% | 200 mld. | |
-8,94% | 149 mld. |
- Beurs
- Aandelen
- Koers KALA
- Onderneming KALA BIO, Inc.